Neuroleptic malignant syndrome during remoxipride treatment. A case report.
Neuroleptic malignant syndrome (NMS) is a rare, life-threatening complication of neuroleptic treatment. The authors describe a case of NMS during treatment with a new atypical neuroleptic, remoxipride. To their knowledge, there are no previously reported cases.
Koponen
H J
HJ
Moisio Hospital, Mikkeli, Finland.
Lepola
U M
UM
Leinonen
E V
EV
D000368:Aged; D001714:Bipolar Disorder / Q000188:drug therapy / Q000523:psychology; D005260:Female; D006801:Humans; D009459:Neuroleptic Malignant Syndrome / Q000209:etiology*; D017330:Remoxipride / Q000009:adverse effects* / Q000627:therapeutic use
D017330:Remoxipride